ASG-5ME

DRUG2 trials

Sponsors

Seagen Inc., Astellas Pharma Inc

Conditions

Gastric NeoplasmsPancreatic NeoplasmsProstate Neoplasms

Phase 1

A Phase 1 Dose Escalation Trial of ASG-5ME in Pancreatic or Gastric Adenocarcinoma

CompletedNCT01166490

Seagen Inc.Gastric Neoplasms, Pancreatic Neoplasms

Start: 2010-07-31End: 2013-07-31Updated: 2013-08-27

A Study to Determine the Maximum Tolerated Dose of ASG-5ME in Subjects With Castration-Resistant Prostate Cancer

CompletedNCT01228760

Astellas Pharma IncProstate Neoplasms

Start: 2010-10-31End: 2013-02-28Updated: 2013-06-07